Endocrine Abstracts

Contents

• CME Training Day Sessions
• • CME Symposium 1
  • • Abstract unavailable

      ea0095cme1.1
    • Abstract unavailable

      ea0095cme1.2
  • CME Symposium 2
  • • Abstract unavailable

      ea0095cme2.1
    • Abstract unavailable

      ea0095cme2.2
  • CME Symposium 3
  • • Abstract unavailable

      ea0095cme3.1
    • Abstract unavailable

      ea0095cme3.2
• Endocrine Main Meeting Sessions
• • CEW Symposium
  • • Developing & delivering a national service for CEW

      ea0095cs1.1
    • Abstract unavailable

      ea0095cs1.2
    • Abstract unavailable

      ea0095cs1.3
  • Endocrine Symposium 1
  • • Abstract unavailable

      ea0095es1.1
    • Abstract unavailable

      ea0095es1.2
  • How Do I? (Endocrine)
  • • Abstract unavailable

      ea0095hdi1.1
    • How do I manage metabolic bone disease of prematurity

      ea0095hdi1.2
  • Debate (Endocrine/Diabetes)
  • • Abstract unavailable

      ea0095d1.1
    • Abstract unavailable

      ea0095d1.2
  • Personal Practice Session
  • • Abstract unavailable

      ea0095pps
• Diabetes Professionals Day Sessions
• • Diabetes Symposium 1
  • • Preparing for a softer landing at diagnosis - how to manage a child with pre-T1D

      ea0095ds1.1
    • Abstract unavailable

      ea0095ds1.2
  • How Do I? (Diabetes)
  • • Abstract unavailable

      ea0095hdi2.1
    • Abstract unavailable

      ea0095hdi2.2
• Diabetes Main Day Sessions
• • Diabetes Symposium 2
  • • Abstract unavailable

      ea0095ds2.1
    • Abstract unavailable

      ea0095ds2.2
    • Abstract unavailable

      ea0095ds2.3
  • Diabetes Symposium 3
  • • Abstract unavailable

      ea0095ds3.1
    • Abstract unavailable

      ea0095ds3.2
    • Abstract unavailable

      ea0095ds3.3
• Nurses’ Day for Endocrine Professionals Sessions
• • Endocrine Symposium 2
  • • Abstract unavailable

      ea0095es2.1
    • Abstract unavailable

      ea0095es2.2
    • Abstract unavailable

      ea0095es2.3
    • Abstract unavailable

      ea0095es2.4
  • Endocrine Symposium 3
  • • Abstract unavailable

      ea0095es3.1
    • Abstract unavailable

      ea0095es3.2
    • Abstract unavailable

      ea0095es3.3
• Oral Communications
• • Oral Communications 1
  • • Swabbing for Staphylococcus in skin reactions to diabetic devices: not a rash decision

      ea0095oc1.1
    • 45,X/46,XY DSD with gender dysphoria: the conundrum around pubertal induction

      ea0095oc1.2
    • Hyperpigmentation related to diabetes technology adhesives: an unusual presentation of Addison's disease in a child with type 1 diabetes mellitus

      ea0095oc1.3
  • Oral Communications 2
  • • A novel maternally inherited GNAS variant in a family with hyperphagia and obesity

      ea0095oc2.1
    • Conquering the Storm: Surgical Intervention Rescues an Adolescent girl with Severe Thyrotoxicosis Refractory to Medical Management

      ea0095oc2.2
    • Hypopituitarism - a rare manifestation in Joubert syndrome: About 4 cases

      ea0095oc2.3
  • Oral Communications 3
  • • The first description of an MC4R variant in a patient with Kallmann syndrome and obesity

      ea0095oc3.1
    • Lessons learned from a case of fungal candida thyroiditis: a rare but serious condition

      ea0095oc3.2
    • A complex case of pituitary gigantism: overcoming challenges in diagnosis and treatment

      ea0095oc3.3
  • Oral Communications 4
  • • Cortisone reductase deficiency: a rare cause of hyperandrogenaemia and premature adrenarche

      ea0095oc4.1
    • A deletion at 20p11.21 region involving FOXA2 causing Congenital Hyperinsulinism and extra pancreatic features

      ea0095oc4.2
    • Primary adrenal insufficiency with muco-candidiasis- a rare cause of familial glucocorticoid deficiency due to thioredoxin reductase deficiency

      ea0095oc4.3
  • Oral Communications 5
  • • Endocrine outcomes in bardet-biedl syndrome from a large single-centre paediatric multidisciplinary clinic

      ea0095oc5.1
    • Gonadotropin treatment for the induction or completion of puberty for males with hypogonadotropic hypogonadism; Two Centre Experience

      ea0095oc5.2
    • Origins of the lower vagina and the role of androgens from 20 years' experience with genitoplasty for 46XX classical congenital adrenal hyperplasia (CAH)

      ea0095oc5.3
    • A survey of current clinical care of children and young people with Klinefelter Syndrome in United Kingdom

      ea0095oc5.4
    • Pre-hypertension genes in the avon longitudinal study of parents and children (ALSPAC) predict higher systolic blood pressure in children from the manchester babyGRO study

      ea0095oc5.5
    • Can clinical, biochemical and genetic parameters help distinguish congenital hypogonadotrophic hypogonadism from self-limited delayed puberty?

      ea0095oc5.6
    • Breast milk-induced hypercalcaemia - a retrospective study to describe biochemical and radiological outcomes if no intervention is offered

      ea0095oc5.7
    • Liraglutide improves metabolic profile, glycaemic dysregulation, quality-of-life and eating behaviours in adolescents with severe obesity

      ea0095oc5.8
    • Home waking salivary cortisone to screen for adrenal insufficiency in children

      ea0095oc5.9
  • Oral Communications 6
  • • An audit on improving the endocrine management of patients with Duchenne Muscular Dystrophy

      ea0095oc6.1
    • Children with hypophosphatasia treated with asfotase alfa: analysis from the UK Patients Cohort

      ea0095oc6.2
    • Initial experiences of using the Paediatric Sleep Questionnaire (PSQ) to screen for obstructive sleep apnoea in a tier-3 paediatric weight management clinic

      ea0095oc6.3
    • Screening for coeliac disease in paediatric patients diagnosed with Graves' Disease

      ea0095oc6.4
    • Growth hormone excess in children with pituitary adenomas associated with endocrine syndromes

      ea0095oc6.5
  • Oral Communications 7
  • • Integrating physical activity in structured education programmes to lower hyperglycaemia in children and young people with type 1 diabetes without increasing risk of hypoglycaemia

      ea0095oc7.1
    • Retrospective audit of the East of England, Children and Young People Diabetes Network, out of hours consortium provision

      ea0095oc7.2
    • Title: How do Accident and Emergency staff perceive new diabetes technologies? A study across two centers

      ea0095oc7.3
    • T1D clinic- a novel approach!

      ea0095oc7.4
    • Leicester Paediatric Diabetes Unit's 'Bridge the Gap' project: Improving access to diabetes technology for children and young people from ethnic minorities and socio-economically deprived families

      ea0095oc7.5
  • Oral Communications 8
  • • Is there reversal of virilisation after commencing medical replacement therapy for 46XX classical congenital adrenal hyperplasia (CAH)?

      ea0095oc8.1
    • Rare variants in the MECP2 gene in girls with central precocious puberty

      ea0095oc8.2
    • Dysregulated pathways reveal NOVEL mechanistic insights underlying HMGA2-related growth failure in Silver Russell Syndrome

      ea0095oc8.3
    • Association of newborn screening of congenital adrenal hyperplasia with outcomes in the first 90 days of life: a multi-centre I-CAH registry analysis of contemporary practice

      ea0095oc8.4
    • Feasibility of integrating an exercise specialist supported by mHealth technology to increase exercise and physical activity in an adolescent Complications from Excess Weight Service: MOTIVATE-CEW

      ea0095oc8.5
  • Oral Communications 9
  • • Experience of the digital version of SEREN (Structured Education Reassuring Empowering Nurturing), Diabetes at Diagnosis module-improving paediatric diabetes care

      ea0095oc9.1
    • Screening for paediatric type 1 diabetes - A qualitative study of parents and stakeholders

      ea0095oc9.2
    • A National Survey on the care and management of Children and Young people with Type 2 Diabetes

      ea0095oc9.3
    • Evaluating the impact of a Health Care Assistant for care of children and young people with type 1 diabetes - [ldquo]Improving the Time to Care[rdquo]

      ea0095oc9.4
    • Impact of using hybrid closed loop system in a tertiary children's hospital: a single centre experience

      ea0095oc9.5
    • How does HbA1c compare with OGTT in identifying patients with Diabetes Mellitus and Pre-Diabetes

      ea0095oc9.6
    • Personalised carbohydrate prescriptions using individualised calculations prevent over prescribing carbohydrate to newly diagnosed children and young people with type 1 diabetes

      ea0095oc9.7
    • CFTR modulators and glucose tolerance in children

      ea0095oc9.8
    • Quality improvement using PDSA cycles improves performance on NPDA key care processes for Birmingham Children's Hospital

      ea0095oc9.9
  • Oral Communications 10
  • • The real-world experience of long acting growth hormone in children with growth hormone deficiency

      ea0095oc10.1
    • A multidisciplinary approach to the growth hormone shortage

      ea0095oc10.2
    • Evaluating the impact of a nurse education refresher session for families who have a child with adrenal insufficiency

      ea0095oc10.3
    • The use of efmody (modified-release hydrocortisone, MRHC) in patients with congenital adrenal hyperplasia (CAH): initial experience and patient feedback

      ea0095oc10.4
    • Parental perspective on genitoplasty for girls with virilising congenital adrenal hyperplasia

      ea0095oc10.5
    • An appraisal on the quality and readability of growth hormone therapy patient information developed by paediatric endocrine societies

      ea0095oc10.6
• Poster Presentations
• • Adrenal 1
  • • Premature adrenarche and cardiometabolic risk - characterisation of a pilot cohort

      ea0095p1
    • Antenatal exposure to steroids, should we worry about neonatal adrenal suppression?

      ea0095p2
    • Case series of non-classical congenital adrenal hyperplasia in childhood

      ea0095p3
    • Patient education for management of sick day episodes in adrenal insufficiency: A systematic review of published literature on structured education programs

      ea0095p4
    • Retrospective review of patients with 21-hydroxylase deficiency (21OHD) Congenital adrenal hyperplasia (CAH) in a tertiary children's hospital

      ea0095p5
    • Bone mineral density in children with congenital adrenal hyperplasia presenting to tertiary care hospital from LMIC

      ea0095p6
    • CortiCit: Development of a hydrocortisone intramuscular injection kit for adrenal crisis

      ea0095p7
    • When management becomes the source of my sorrow! (prolonged steroids' side effects and adrenal insufficiency from the patient's perspective)

      ea0095p8
    • First case recognized as autoimmune polyglandular syndrome type 2 with double seronegative myasthenia gravis - A case report-from Pakistan

      ea0095p9
  • Bone
  • • LC-MS/MS measurements of serum zoledronate in children and young people receiving treatment - findings from the Moving Towards Individualised BisphosphonatE Therapy (TIBET) study

      ea0095p10
    • Assessment of children's bone health: Establishing paediatric reference (prefer study) values for 1,25 vitamin D

      ea0095p11
    • Impairment of muscle mass and muscle function in osteogenesis imperfecta: A systematic review

      ea0095p12
    • Cessation of burosumab treatment in adolescent patients with XLH: A multi-centre case series

      ea0095p13
    • Clinical utility of individual biochemical markers in screening for metabolic bone disease of prematurity

      ea0095p14
    • Stuve Wiedemann syndrome - case series of 3 cases

      ea0095p15
    • Infantile hypocalcemic seizures secondary to maternal vitamin D deficiency followed by persistent hypomagnesemia

      ea0095p16
  • Diabetes 1
  • • Management of type 1 diabetes and HbA1c audit

      ea0095p17
    • Acceptability of a general population childhood type 1 diabetes screening programme: a qualitative study - T1 Early

      ea0095p18
    • Improved glycaemic control with insulin hybrid closed-loop system

      ea0095p19
    • Abstract unavailable

      ea0095p20
    • Don't forget bone health: Increased fracture risk in type 1 diabetes

      ea0095p21
    • Exploring the social and clinical impact of a residential activity camp for children and families with type 1 diabetes: A video-based study of camp Charnwood

      ea0095p22
    • Atrial natriuretic peptide and copeptin levelsrelationship with serum osmolality in pediatric patients with diabetic ketoacidosis

      ea0095p23
    • A UK survey on the screening and management of childhood pre-clinical type 1 diabetes

      ea0095p24
    • Evaluating the impact of planned ward admissions in High HbA1c patients

      ea0095p25
    • Lipoprotein Lipase (LPL) gene mutation in a girl with diabetic ketoacidosis, acute pancreatitis and hypertriglyceridemia

      ea0095p26
    • Type 1 diabetes associated with primary sclerosing cholangitis and inflammatory bowel disease - a rare autoimmune combination

      ea0095p27
    • Enhancing engagement in a diabetes camp for families and young people: A promising approach to empowerment and sustainability during a cost of living crisis

      ea0095p28
  • Diabetes 2
  • • Introduction of under-fives type 1 diabetes clinic improves glycaemic control through rapid access to automated insulin delivery systems

      ea0095p29
    • Type 1 diabetes in pre-school children: Identifying targets for quality improvement through a countywide review evaluating clinical presentation, management, and outcomes

      ea0095p30
    • Abstract unavailable

      ea0095p31
    • A new educational tool for prevention of DKA at diagnosis of type 1 diabetes

      ea0095p32
    • Neonatal diabetes: A challenging case scenario and therapeutic considerations

      ea0095p33
    • Effect of the T-Slim pump with control IQ hybrid closed loop system on physiological and psychological outcomes in children with type 1 diabetes in gloucestershire

      ea0095p34
    • Use of sensor augmented pump therapy is safe and effective in patients with significant deprivation and high risk HBA1c

      ea0095p35
    • Abstract unavailable

      ea0095p36
    • Examining the relationship between social deprivation, health outcomes and technology uptake in a district general hospital setting - are we providing equity in our service?

      ea0095p37
    • Abstract unavailable

      ea0095p38
    • Right diagnosis, right treatment: Think MODY early in children who present with symptoms of diabetes

      ea0095p39
  • Gonadal, DSD and Reproduction 1
  • • Systematic review and meta-analysis of spermatogenesis rates after pubertal induction with gonadotropins in males with hypogonadotropic hypogonadism

      ea0095p40
    • A retrospective analysis of clinical characteristics, testosterone therapy, and comorbidity screening for klinefelter syndrome: Insights from a UK tertiary centre over the last two decades

      ea0095p41
    • Establishing diagnoses in a cohort of boys from East London with 46XY DSD and severe hypospadias

      ea0095p42
    • Long-term psychosocial and functional outcomes after genitoplasty in virilising congenital adrenal hyperplasia

      ea0095p43
    • Novel association of NUP107 variants in XY DSD

      ea0095p44
    • 17[beta]-HSD3 deficiency: A single centre experience

      ea0095p45
    • X-Chromosome genomic alteration leading to primary ovarian insufficiency in an adolescent: A case study

      ea0095p46
    • A rare cause of gonadal dysgenesis due to TOE1 gene mutation

      ea0095p47
    • Mayer-Rokitansky-Kuster-Hauser (MRKH) syndrome - two cases presenting to a large UK Paediatric Endocrinology Centre

      ea0095p49
    • A rare disease of Kallmann syndrome: First case report from Pakistan

      ea0095p50
  • Late effects of cancer treatment
  • • Glucagon-like peptide-1 (GLP-1) receptor agonists as a new treatment option for hypothalamic obesity in the paediatric population: Preliminary data from a tertiary paediatric endocrine centre

      ea0095p51
    • Abstract unavailable

      ea0095p52
    • Precocious puberty and other endocrine disorders during mitotane treatment for pediatric adrenocortical carcinoma - cases series

      ea0095p53
  • Miscellaneous/other 1
  • • Incidence, aetiology and outcome of infants presenting with low sodium and high potassium - population surveillance study in Wales

      ea0095p54
    • Phenotyping hypophosphatasia using UK primary care electronic health records

      ea0095p55
    • Use of long-acting somatostatin analogue in a paediatric patient with MEN1 - a case report

      ea0095p56
    • Endocrine complications in paediatric patients with transfusion-dependent thalassaemia

      ea0095p57
    • Endocrine presentation of a renal disorder

      ea0095p58
    • Results from learner's feedback on the use of free, globally accessible CME-accredited e-learning modules in paediatric endocrinology and diabetes

      ea0095p59
  • Obesity 1
  • • Abstract unavailable

      ea0095p60
    • The use of cardiopulmonary exercise testing (CPET) for assessment and guiding interventions in adolescents with obesity

      ea0095p61
    • Clinical characteristics and complications of excess weight (CEW) seen in multi-disciplinary tier-3 paediatric weight management services: a two centre experience

      ea0095p62
    • The positive effect of liraglutide treatment on body mass index and metabolic profile in adolescents with obesity

      ea0095p63
    • Developing TechnOlogy to Support ChAnge (TOSCA tudy) for young people and their families seen in the complications of excess weight service

      ea0095p64
    • A contextual evaluation of complications of excess weight (CEW) clinics in the Midlands region, England

      ea0095p65
    • A higher proportion of physical and mental health CEW in areas of higher socio-economic deprivation demands urgent action: Comparative data across two regions of UK

      ea0095p66
    • Making every contact count - reconnecting oral health to holistic paediatric care in the management of childhood obesity

      ea0095p67
    • Case report: Potocki-lupski syndrome (PTLS) with obesity

      ea0095p68
  • Pituitary and Growth 1
  • • Segmental growth relationships between fetal and postnatal measures in the Manchester BabyGRO Study

      ea0095p69
    • Novel insights into genetic causes of childhood growth failure from patients recruited to the 100 000 Genomes Project

      ea0095p70
    • The oxytocin system in craniopharyngioma: A systematic review

      ea0095p71
    • Using basal LH to predict response on luteinising hormone releasing hormone stimulation test

      ea0095p72
    • Significance of targeted gene panel sequencing in early childhood growth failure

      ea0095p73
    • Effect of steroid therapy in a 16-year-old girl with lymphocytic hypophysitis - case report

      ea0095p74
    • Growth hormone deficiency associated with BRAF-related cardiofaciocutaneous syndrome

      ea0095p75
    • Monozygotic twins with short stature due to temple syndrome and GH plus GnRHa treatment in one twin

      ea0095p76
  • Thyroid 1
  • • The dynamic response of the thyroid hormone axis in central hypothyroidism

      ea0095p77
    • Outcome of a case of foetal goitre

      ea0095p78
    • Cardiac presentation of a common endocrine condition

      ea0095p79
    • Subclinical hypothyroidism in children, when to treat

      ea0095p80
  • Adrenal 2
  • • National service evaluation of care for children and young people with congenital adrenal hyperplasia in the UK: Survey responses from patients and clinicians

      ea0095p81
    • Cortisol measurement using immunoassay versus liquid chromatography-tandem mass spectrometry in infants with congenital adrenal hyperplasia

      ea0095p82
    • A critical appraisal of online patient education resources for the management of sick day episodes in adrenal insufficiency

      ea0095p83
    • Evaluation of early morning cortisol levels compared to short synacthen test to assess adrenal function

      ea0095p84
    • Single-centre experience of the use of anastrozole in prepubertal boys with advanced bone age

      ea0095p85
    • An international study of the association between local health care resources and acute adrenal insufficiency events in children with congenital adrenal hyperplasia

      ea0095p86
    • A case of 17 [alpha]-hydroxylase enzyme deficiency; a rare cause of adrenal insufficiency

      ea0095p87
    • A case report of profound hyponatremia unveiling Addison's disease

      ea0095p88
  • Bone 2
  • • Establishing reference interval values of fibroblast growth factor 23 in paediatrics population

      ea0095p89
    • Systematic review of pharmacological and non-pharmacological therapies for prevention and treatment of osteoporosis in Duchenne muscular dystrophy

      ea0095p90
    • Developing national consensus on management of osteoporosis in duchenne muscular dystrophy in the transition to adult care within the UK adult NorthStar network

      ea0095p91
    • Evaluation of MRI screening practices for foramen magnum stenosis in achondroplasia patients at Evelina London Children's Hospital

      ea0095p92
    • Hematopoietic stem cell transplantation partially rescued the bone phenotype and prevented upper airway obstruction in a boy with pycnodysostosis: A case report

      ea0095p93
    • From osteogenesis imperfecta to hypophosphataemic rickets; a story of missed or mis-diagnosis

      ea0095p94
    • Unusual presentation of Isolated Hypoparathyroidism in a young adolescent

      ea0095p95
  • Diabetes 3
  • • EarLy Surveillance for Autoimmune type 1 diabetes (ELSA) - paediatric, general population screening in the UK

      ea0095p96
    • Disparities in using an insulin pump to manage Type1 DM Evelina Children's Hospital experience

      ea0095p97
    • Abstract unavailable

      ea0095p98
    • Improving diabetes outcomes using an intensive structured education programme during first year of care after diagnosis

      ea0095p99
    • The impact of COVID-19 and social deprivation on the outcomes of type 1 diabetes in children

      ea0095p100
    • Creation of a simple, online 'hello quiz' for diabetes clinics- to help tailor appointments, improve communication, and aid service development

      ea0095p101
    • Prohormone convertase 1/3 deficiency can be associated with diabetes mellitus in childhood

      ea0095p102
    • Dietary intervention for the management of adolescent type 2 diabetes mellitus: A systematic review

      ea0095p103
    • Sodium point of care testing at home in diabetes insipidus: A case report

      ea0095p104
    • Management of diabetic ketoacidosis in 0 to 16 years presenting to the Southern Health and Social Care Trust between January 2020 and September 2022

      ea0095p105
    • 'Getting it right from the start' - A quality improvement project to reduce inequalities in access to diabetes related technology

      ea0095p106
    • Levelling the Levemir: Are we prescribing too much long-acting insulin to children at diagnosis?

      ea0095p107
  • Diabetes 4
  • • The impact of COVID-19 and ethnicity on the outcomes of type 1 diabetes in children

      ea0095p108
    • What do young people with type 1 diabetes really think about the new advances in diabetes technology?

      ea0095p109
    • Assessing diabetic ketoacidosis management: an audit of clinical practices at bristol royal hospital for children

      ea0095p110
    • Impact of socio-economic deprivation on the management of type 1 diabetes in children

      ea0095p111
    • An unusual case of hyperosmolar hyperglycaemic state

      ea0095p112
    • Regional audit on presentation in diabetic ketoacidosis(DKA) at the manifestation of type1 diabetes in children and young people within Yorkshire and Humber region (YH)

      ea0095p113
    • Breaking down the barriers in allergic contact dermatitis to continuous glucose monitors

      ea0095p114
    • Neonatal diabetes experience from a single centre

      ea0095p115
    • Abstract unavailable

      ea0095p116
    • A rare case of metabolic encephalopathy complicating diabetic ketoacidosis

      ea0095p117
    • Adaptation of local practice guidelines increases paediatric doctor confidence in prescribing multiple daily injections for newly diagnosed type 1 diabetics at discharge

      ea0095p118
    • A rare case of diabetes mellitus and congenital deafness in an 18 month old girl with Wolfram like syndrome

      ea0095p119
  • Gonadal, DSD and Reproduction 2
  • • Multidisciplinary team management in an andrology service for Klinefelter Syndrome: A review of current practice

      ea0095p120
    • Characterising puberty in children and young people with Alstrom Syndrome

      ea0095p121
    • Characterisation of children and young people (CYP) presenting with differences in sex development (DSD) beyond the neonatal period: A single centre retrospective observational study

      ea0095p122
    • Testosterone therapy in Duchenne muscular dystrophy and longitudinal bone growth with metacarpophalangeal length measurement

      ea0095p123
    • The value of the stimulated testosterone: dihydrotestosterone ratio in 46, XY DSD due to 5alpha-reductase type 2 deficiency

      ea0095p124
    • Audit of the investigations and treatment for adolescents with irregular menstruation/suspected Polycystic Ovarian Syndrome at The Noah's Ark Children's Hospital for Wales

      ea0095p125
    • A case of 46, XY differences of sex development (DSD) due to FKBP4 deficiency: A novel candidate of androgen insensitivity syndrome?

      ea0095p126
    • Complexities of gender assignment in 17[beta]-hydroxysteroid dehydrogenase type 3 deficiency

      ea0095p127
    • Challenging clinical scenario: Germ cell tumor masquerading as peripheral precocious puberty in a one-year-old boy from Pakistan

      ea0095p128
    • Kallmann syndrome: A FGFR1 mutation

      ea0095p129
  • Miscellaneous/other 2
  • • Patient attendance in virtual paediatric and adolescent gynaecology clinics since the COVID-19 pandemic

      ea0095p130
    • Hypernetwork analysis: A novel approach for epigenome analysis, with Kabuki syndrome as an exemplar

      ea0095p131
    • Initial accuracy and family experience evaluation of the Dexcom G7 continuous glucose monitor for hypoglycaemia due to hyperinsulinism

      ea0095p132
    • Patient and public involvement: Techniques used to engage with children and young people about research in congenital adrenal hyperplasia

      ea0095p133
    • Abstract unavailable

      ea0095p134
    • Rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neuroendocrine tumors (ROHHADNET) syndrome: A case report

      ea0095p135
    • Aortic valve disease in two females with congenital hyperinsulinism due to activating GCK mutation

      ea0095p136
  • Obesity 2
  • • Effects of daily glucocorticoid on body composition in Duchenne muscular dystrophy: Isolating fat mass increase to establish weight management interventions

      ea0095p137
    • Genetics of early onset obesity: Initial data from a tier 3 paediatric weight management service

      ea0095p138
    • The prevalence of monogenic obesity in Turkish children with non-syndromic early onset obesity. A multicenter study

      ea0095p139
    • Evaluation of psychological and musculoskeletal outcomes in a tertiary weight management service at the Royal Manchester Children's Hospital

      ea0095p140
    • Continuous glucose monitoring highlights the limited effect of lifestyle intervention on early glycaemic dysregulation in CYP with severe obesity

      ea0095p141
    • Immune modulatory response to rituximab in ROHHAD syndrome

      ea0095p142
    • Significantly higher prevalence of glycaemic dysregulation in CYP with severe obesity as identified using CGM despite normal OGTT

      ea0095p143
    • The impact of socio-economic deprivation on the Complications from Excess weight; Insights from a Tier 3 weight management service

      ea0095p144
  • Pituitary and Growth 2
  • • Pathways linking early growth to cardiometabolic disease risk development: Novel insights from the Manchester BabyGRO Study

      ea0095p145
    • Predictive value of a basal LH instead of an LHRH test in assessing pubertal suppression in children on GnRH agonist therapy

      ea0095p146
    • Testing a screening algorithm for the identification of growth-disorders for use in UK children

      ea0095p147
    • An audit of the management of childhood-onset growth hormone deficiency (CO-GHD) at completion of linear growth

      ea0095p148
    • Standard clinical diagnostic criteria for Silver-Russell Syndrome frequently overlooks monogenic causes

      ea0095p149
    • 2 cases of congenital hypopituitarism due to pituitary stalk interruption syndrome (PSIS) diagnosed in the early infantile period

      ea0095p150
    • Evaluation of etiology and clinical feature of precocious puberty among children presenting in a pediatric endocrinology department in a tertiary care hospital

      ea0095p151
    • An unusual presentation of a giant prolactinoma

      ea0095p152
  • Thyroid 2
  • • Four siblings with congenital hypothyroidism-really?

      ea0095p153
    • Aetiology and the mode of presentation of congenital hypothyroidism - a 10 year single centre experience in a tertiary care centre in Sri Lanka

      ea0095p154
    • Thyroid hormones and the kidneys: Don't forget to check renal function in thyroid disease

      ea0095p155
    • Interference of heterophilic antibodies with thyroid stimulating hormone (TSH) assay leading to inappropriate treatment

      ea0095p156
    • Managing hypothyroidism in congenital nephrotic syndrome: A case report

      ea0095p157
  • Miscellaneous/other 2 (1)
  • • A young girl with papillary thyroid cancer, could it be DICER1 Syndrome?

      ea0095p158